1. Immortalized striatal precursor neurons from Huntington's disease patient-derived iPS cells as a platform for target identification and screening for experimental therapeutics. Issue 24 (22nd July 2021) Authors: Akimov, Sergey S; Jiang, Mali; Kedaigle, Amanda J; Arbez, Nicolas; Marque, Leonard O; Eddings, Chelsy R; Ranum, Paul T; Whelan, Emma; Tang, Anthony; Wang, Ronald; DeVine, Lauren R; Talbot, Conover C; Cole, Robert N; Ratovitski, Tamara; Davidson, Beverly L; Fraenkel, Ernest; Ross, Christopher A Journal: Human molecular genetics Issue: Volume 30:Issue 24(2021) Page Start: 2469 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Treatment with JQ1, a BET bromodomain inhibitor, is selectively detrimental to R6/2 Huntington's disease mice. (7th November 2019) Authors: Kedaigle, Amanda J; Reidling, Jack C; Lim, Ryan G; Adam, Miriam; Wu, Jie; Wassie, Brook; Stocksdale, Jennifer T; Casale, Malcolm S; Fraenkel, Ernest; Thompson, Leslie M Journal: Human molecular genetics Issue: Volume 29:Number 2(2020) Page Start: 202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗